Curza Competitors and Similar CompaniesClear all
Curza's competitors and similar companies include GBT (Global Blood Therapeutics), Kamada Pharmaceuticals, Bath ASU and Yamo Pharmaceuticals.
 Curza Curza Global is a small-molecule therapeutics company that develops drugs for infectious diseases and oncology. |  GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. |  Kamada Pharmaceuticals Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications. |  Yamo Pharmaceuticals Yamo Pharmaceuticals is a company developing L1-79, a therapy that targets the core symptoms of autism. | ||
Founding Date | Founding Date 2021 | Founding Date 2012 | Founding Date 1990 | Founding Date 2006 | Founding Date N/A |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Salt Lake City, US HQ | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB | Locations Rehovot, IL HQ Beit Kama, IL | Locations Corsham, GB HQ | Locations HQ |
Employees | Employees 186% increase | Employees 352106% increase | Employees 420 | Employees 903% decrease | Employees 6 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 4.4 b | Valuation ($) 317 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $194.7m (FY, 2021) | Revenue (est.) $180.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $3.3m (FY, 2021) | Cost of goods $72.1m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Net income | Net income N/A | Net income ($303.1m) (FY, 2021) | Net income $20.2m (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 88.7m | Total funding raised $ 90m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View companyKamada Pharmaceuticals
HQ
Rehovot, IL
Employees
420
Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.
View company
Bath ASU
HQ
Corsham, GB
Employees
90↓ 3% decrease
Bath ASU (also known as Qualasept) is a pharmaceutical specials manufacturer.
View companyYamo Pharmaceuticals
HQ
Employees
6
Yamo Pharmaceuticals is a company developing L1-79, a therapy that targets the core symptoms of autism.
View company